Jun 05, 2025
Foundation Receives Record Number of Grant Entries for 2025
In the 2025 grant cycle, The Doctors Company Foundation received a record number of Letters of Intent—107 letters were submitted by the March 19 deadline. The Foundation’s grant review committee will now have the challenging task of evaluating those submissions to select a limited number of projects to move forward to the second phase of the grant making process.
From
The Doctor’s Advocate
Search
Video Nov 18, 2022
What to Expect from Litigation: Dr. Grollo's Perspective
Dennis Grollo, MD, a family physician, describes a malpractice case against him involving a long-time patient and allegations of using an out-of-state pharmacy. Dr. Grollo worked as a team with his attorney and The Doctors Company claims specialist to provide a strong defense with the support of medical and phone records. In the end, the jury exonerated him.
August 01, 2025, Healthcare Risk Management
DOJ Targeting Healthcare for False Claims Act Enforcement
Federal regulators and law enforcement are looking at healthcare organizations for False Claims Act (FCA) violations. Richard F. Cahill, JD, Vice President and Associate General Counsel at The Doctors Company, provides recommendations for healthcare providers to review their compliance programs to avoid FCA enforcement actions.
Office-Based Medical Malpractice Claims
Ensuring patient safety is the goal in each office encounter. As evidenced by medical malpractice claims, however, harmful errors can occur that lead to poor outcomes for patients. We have conducted an analysis to better understand the underlying administrative and clinical systems factors that contribute to office-based medical malpractice claims.
Midwives Liability Insurance Guide
Midwives face distinct, significant, and long-lasting liability risks, and providing excellent care is not enough to mitigate them. Careful consideration of liability coverage options is essential for midwives to protect their licenses, reputations, professional and geographic mobility, and long-term financial health.
Cost and Impact of Defensive Medicine
Physicians practice defensive medicine all the time—some acknowledge and accept it, while others believe it is untrue and unconscionable. The Doctors Company CEO and Chairman Richard E. Anderson, MD, FACP, examines the pervasive nature of defensive medicine in this article.
Professional Education
Module 6: Controlled Substance Utilization Review and Evaluation System (CURES) (Innovations and Smart Approaches in Safe Prescribing)
This program reviews the CURES electronic database for Schedule II, III, IV, V controlled substance prescriptions dispensed in California, including time requirements involved when dispensing information needs to be reported (a controlled substance is released to the patient or patient's representative). This module will examine how non-DEA licensed physicians and surgeon practitioners can access CURES data. This module consists of four audio-filled videos. To successfully complete this course, you need to achieve a passing score of 80 percent in the post-test questions.
NJ PURE Exclusive Agreement
NJ Physicians United Reciprocal Exchange (NJ PURE) announced today it is exiting the medical malpractice insurance marketplace and has entered into a relationship designed to offer its insureds access to a leading A rated medical liability carrier with The Doctors Company Risk Retention Group (RRG).
2025 Great Place to Work Certification
The Doctors Company, the nation’s largest physician-owned medical malpractice insurer, announced today it has been Certified as a Great Place to Work for the third time. The recognition is based entirely on what current employees say about working at The Doctors Company, with 89 percent of employees saying it’s a great place to work.
February 26, 2025, STAT News
Are We Adopting AI Scribes Based on…Vibes?
This article examines AI-driven scribe technologies and their marketing claims. It also cites the article "Ambient Listening–Legal and Ethical Issues," in which I. Glenn Cohen, JD; Julie Ritzman, MBA, CPHRM; and Richard F. Cahill, JD, provide a comprehensive analysis of the legal and ethical considerations associated with the use of ambient listening technologies in healthcare settings.
